Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 806

1.

Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

House AA, Wanner C, Sarnak MJ, Piña IL, McIntyre CW, Komenda P, Kasiske BL, Deswal A, deFilippi CR, Cleland JGF, Anker SD, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, McCullough PA; Conference Participants.

Kidney Int. 2019 Apr 30. pii: S0085-2538(19)30276-5. doi: 10.1016/j.kint.2019.02.022. [Epub ahead of print]

PMID:
31053387
2.

The Management of Hypertension in 2018: What Should the Targets Be?

Ali W, Bakris G.

Curr Hypertens Rep. 2019 Apr 25;21(6):41. doi: 10.1007/s11906-019-0946-7. Review.

PMID:
31025203
3.

Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Cheung AK, Chang TI, Cushman WC, Furth SL, Ix JH, Pecoits-Filho R, Perkovic V, Sarnak MJ, Tobe SW, Tomson CRV, Cheung M, Wheeler DC, Winkelmayer WC, Mann JFE; Conference Participants.

Kidney Int. 2019 May;95(5):1027-1036. doi: 10.1016/j.kint.2018.12.025.

PMID:
31010478
4.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators.

Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Erratum in: Lancet. 2019 May 11;393(10184):1936.

PMID:
30995972
5.

Perspective on the New Blood-Pressure Guidelines.

Bakris G, Sorrentino M.

Eur Heart J. 2018 Sep 1;39(33):3008-3009. doi: 10.1093/eurheartj/ehy280. No abstract available.

PMID:
30990868
6.

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW; CREDENCE Trial Investigators.

N Engl J Med. 2019 Apr 14. doi: 10.1056/NEJMoa1811744. [Epub ahead of print]

PMID:
30990260
7.

Similarities and Differences Between the ACC/AHA and ESH/ESC Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.

Bakris G.

Circ Res. 2019 Mar 29;124(7):969-971. doi: 10.1161/CIRCRESAHA.118.314664. No abstract available.

PMID:
30920926
8.

Redefining diuretics use in hypertension: why select a thiazide-like diuretic?

Burnier M, Bakris G, Williams B.

J Hypertens. 2019 Mar 14. doi: 10.1097/HJH.0000000000002088. [Epub ahead of print]

PMID:
30882593
9.

Barriers to guideline mandated renin-angiotensin inhibitor use: focus on hyperkalaemia.

Vijayakumar S, Butler J, Bakris GL.

Eur Heart J Suppl. 2019 Feb;21(Suppl A):A20-A27. doi: 10.1093/eurheartj/suy030. Epub 2019 Feb 26.

10.

Blood Pressure Lowering and Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2is): More Than Osmotic Diuresis.

Sternlicht H, Bakris GL.

Curr Hypertens Rep. 2019 Feb 12;21(2):12. doi: 10.1007/s11906-019-0920-4. Review.

PMID:
30747296
11.

Novel therapies for diabetic kidney disease.

Cherney DZI, Bakris GL.

Kidney Int Suppl (2011). 2018 Jan;8(1):18-25. doi: 10.1016/j.kisu.2017.10.005. Epub 2017 Dec 29. Review.

12.

Update on reducing the development of diabetic kidney disease and cardiovascular death in diabetes.

Bakris GL.

Kidney Int Suppl (2011). 2018 Jan;8(1):1. doi: 10.1016/j.kisu.2017.10.002. Epub 2017 Dec 29. No abstract available.

13.

Controversies in the 2017 ACC/AHA Hypertension Guidelines: Who Can Be Eligible for Treatments Under the New Guidelines? - An Asian Perspective.

Ihm SH, Bakris G, Sakuma I, Sohn IS, Koh KK.

Circ J. 2019 Feb 25;83(3):504-510. doi: 10.1253/circj.CJ-18-1293. Epub 2018 Dec 29.

14.

MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol.

Parati G, Agabiti-Rosei E, Bakris GL, Bilo G, Branzi G, Cecchi F, Chrostowska M, De la Sierra A, Domenech M, Dorobantu M, Faria T, Huo Y, Jelaković B, Kahan T, Konradi A, Laurent S, Li N, Madan K, Mancia G, McManus RJ, Modesti PA, Ochoa JE, Octavio JA, Omboni S, Palatini P, Park JB, Pellegrini D, Perl S, Podoleanu C, Pucci G, Redon J, Renna N, Rhee MY, Rodilla Sala E, Sanchez R, Schmieder R, Soranna D, Stergiou G, Stojanovic M, Tsioufis K, Valsecchi MG, Veglio F, Waisman GD, Wang JG, Wijnmaalen P, Zambon A, Zanchetti A, Zhang Y.

BMJ Open. 2018 Dec 19;8(12):e021038. doi: 10.1136/bmjopen-2017-021038.

15.

Creatinine Bump Following Antihypertensive Therapy.

Bakris GL, Agarwal R.

Hypertension. 2018 Dec;72(6):1274-1276. doi: 10.1161/HYPERTENSIONAHA.118.12051. No abstract available.

PMID:
30571245
16.

Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial).

Vaduganathan M, White WB, Charytan DM, Morrow DA, Liu Y, Zannad F, Cannon CP, Bakris GL; EXAMINE Investigators.

Am J Cardiol. 2019 Feb 1;123(3):382-391. doi: 10.1016/j.amjcard.2018.10.035. Epub 2018 Nov 6.

PMID:
30477800
17.

Intradialytic Hypotension: Is Midodrine the Answer?

Hammes M, Bakris GL.

Am J Nephrol. 2018;48(5):378-380. doi: 10.1159/000494805. Epub 2018 Nov 13. No abstract available.

18.

Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial.

de Zeeuw D, Renfurm RW, Bakris G, Rossing P, Perkovic V, Hou FF, Nangaku M, Sharma K, Heerspink HJL, Garcia-Hernandez A, Larsson TE.

Lancet Diabetes Endocrinol. 2018 Dec;6(12):925-933. doi: 10.1016/S2213-8587(18)30289-4. Epub 2018 Nov 6.

PMID:
30413396
19.

Ambulatory Blood Pressure Monitoring.

Polonsky TS, Bakris GL.

JAMA. 2018 Nov 6;320(17):1807-1808. doi: 10.1001/jama.2018.14856. No abstract available.

PMID:
30398582
20.

Average Clinician-Measured Blood Pressures and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Ischemic Heart Disease in the EXAMINE Trial.

White WB, Jalil F, Cushman WC, Bakris GL, Bergenstal R, Heller SR, Liu Y, Mehta C, Zannad F, Cannon CP.

J Am Heart Assoc. 2018 Oct 16;7(20):e009114. doi: 10.1161/JAHA.118.009114.

Supplemental Content

Loading ...
Support Center